Milestone Scientific Inc. (MLSS)
NYSE: MLSSHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MLSS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $21.75M
- EPS (TTM)
- -$0.04
- Dividend yield
- None
- 52-week range
- 0.22 – 0.58
- Day range
- 0.231 – 0.2523
- Volume / Avg
- 108.80K / 100.50K
- Beta
- —
- Shares outstanding
- 90.61M
52-week range
MLSS stock today
Shares of Milestone Scientific (MLSS) finished lower on Nov 20 at $0.24, a drop of 0.83% or $0.002 per share, versus the S&P 500's 3.70% decline. Shares are 58.6% below their 52-week high of $0.58, set on Aug 13, 2026 and 9.1% above the 52-week low of $0.22, near the bottom of the past year's range. MLSS is down 11.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 20.0%.
Milestone Scientific has posted a net loss over the last twelve months (EPS of -$0.04), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Milestone Scientific
Company profileMilestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Eric C. Hines
- Headquarters
- Roseland, NJ
- Employees
- 15
- IPO year
- 2015
- Website
- milestonescientific.com
Financial highlights
Full financialsIn fiscal 2025, Milestone Scientific generated $9.0 million in revenue, up 4.0% from fiscal 2024. Milestone Scientific reported a net loss of $5.7 million, compared with a loss of $4.7 million a year earlier. Gross margin was 71.4% (down from 74.6%) and operating margin -63.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $8.97M | $8.63M | $9.83M | $8.81M | $10.30M |
| Growth | +3.99% | -12.19% | +11.60% | -14.54% | +89.52% |
| Net income | $-5.72M | $-4.71M | $-6.93M | $-8.71M | $-6.82M |
| EPS (diluted) | $-0.07 | $-0.06 | — | — | $-0.10 |
Analyst forecast
ForecastConsensus (2 analysts)
none
Avg. price target
$1.25+420.83%
- Strong buy 1
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 13, 2026
- EPS actual vs est.
- $-0.01 vs —
MLSS news
All MLSS news- Milestone Scientific (MLSS) Q3 2026 Earnings Call TranscriptNasdaqMLSS, LEN.B
- Milestone Scientific Inc. Q3 Sales DeclineNasdaq
- Milestone Scientific Reports Financial Results for Third Quarter 2026GlobeNewswire
- CORRECTION: Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference CallGlobeNewswire
- Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference CallGlobeNewswire
- Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural ProceduresGlobeNewswire
Milestone Scientific peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TLIHTen-League International Holdings Limited | 5.79 | +0.70% | $17.03M | vs MLSS |
| MYOMyomo Inc. | 0.811 | -3.45% | $32.52M | vs MLSS |
| CUPRCuprina Holdings (Cayman) Limited Class A | 1.41 | -6.00% | $10.79M | vs MLSS |
| HSCSHeartSciences Inc. | 1.81 | -10.84% | $10.42M | vs MLSS |
| OPHICollPlant Biotechnologies Ltd | 3.13 | -2.49% | $9.63M | vs MLSS |
| FGIFGI Industries Ltd. | 4.90 | -6.84% | $9.46M | vs MLSS |
| MAMOMassimo Group | 0.8405 | +3.40% | $35.00M | vs MLSS |
| LFWDLifeward Ltd. | 2.80 | -5.30% | $7.96M | vs MLSS |
Indexes, lists and sector
Milestone Scientific stock FAQ
What is Milestone Scientific's stock price today?
MLSS last traded at $0.24 as of Nov 20, 4:00 PM EST, down 0.83% on the day. Prices are delayed at least 15 minutes.
Does Milestone Scientific pay a dividend?
No. Milestone Scientific does not currently pay a regular cash dividend.
Who is Milestone Scientific's CEO?
Mr. Eric C. Hines is the chief executive officer of Milestone Scientific Inc., which has about 15 employees.
Has MLSS ever split its stock?
Yes. The most recent MLSS stock split was a 1-for-3 split on Jan 14, 2004.
What is the MLSS 52-week high?
The 52-week high for MLSS is $0.58 and the 52-week low is $0.22. The stock is currently 58.6% below its high.